Elsevier

Chemosphere

Volume 303, Part 2, September 2022, 135005
Chemosphere

The involvement of copper, circular RNAs, and inflammatory cytokines in chronic respiratory disease

https://doi.org/10.1016/j.chemosphere.2022.135005Get rights and content

Highlights

  • Circular RNA, circ_0008882, is related to chronic respiratory disease.

  • Expression of circ_0008882 decreases after copper exposure in vitro and in vivo.

  • IL-6 and IL-8, induced by copper, are inhibited by overexpression of circ_0008882.

Abstract

Exposure to high concentrations of copper is associated with pulmonary inflammation and chronic respiratory disease (CRD). Epigenetic modulation of noncoding RNAs contributes to the development of several CRDs. It is unknown whether epigenetic modulation is involved in copper mediated pulmonary inflammation and CRD. We conducted a case-control study of 101 CRD cases and 161 control subjects in Shijiazhuang, China, and evaluated circRNAs and cytokine levels (IL-6 and IL-8) by qPCR and ELISA. Urinary copper concentration was determined by inductively coupled plasma mass spectrometry. Linear mixed models and generalized linear mixed models were used to assess the associations of circRNAs with CRD, urinary copper, and cytokines. We exposed the human bronchial epithelial cell line, 16HBE, to copper and assessed the functional role of a circRNA, circ_0008882, by RNA overexpression. Cellular location of circ_0008882 was assessed by separation of nuclear and cytoplasmic RNAs. Nine circRNAs were associated with an increased risk for CRDs, while the relative expression of circ_0008882 was decreased after copper exposure in vitro and in vivo. Copper exposure stimulated 16HBE cells to release proinflammatory IL-6 and IL-8. The release of the cytokines was inhibited by overexpression of circ_0008882. These results suggest a role for circ_0008882 in the regulation of CRD associated inflammation following copper exposure.

Introduction

Chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung that are the most common non-communicable diseases worldwide. In 2017, approximately 545 million people in the world were estimated to suffer from CRDs, with an increase of 39.8% since 1990 (Collaborators, 2020). Inflammation is the most common CRD pathological manifestation (Aghasafari, 2019; Barnes et al., 2015), commonly accompanied by dysregulated cytokine production (Hong et al., 2017; Ouyang and O'Garra, 2019), and in particular IL-6 and IL-8 (De Moraes et al., 2014; Higham et al., 2018). High levels of plasma IL-6 and IL-8 have been observed in chronic obstructive pulmonary disease (COPD) patients.

Copper is a naturally occurring heavy metal that is essential to life, playing an important role in the maturation and function of lung immune cells, the development of the airway microbiome, and disease (Gehring et al., 2015; Healy et al., 2021; Tanrikulu et al., 2011). At high concentrations, copper can be toxic. Copper exposure has been associated with increased levels of inflammatory cytokines (Ma et al., 2020; Reisgen et al., 2020; Samet et al., 1998) as well as an increased risk for CRDs (Healy et al., 2021; Zhang et al., 2021). However, how these associations are connected is not well understood.

Epigenetic modulation of noncoding RNAs contributes to the development of several CRDs including asthma, COPD, lung cancer, and emphysema (Li et al., 2019; Lou et al., 2020; Shen et al., 2020). Circular RNAs (circRNAs) are noncoding RNAs that play a role in cell proliferation, metastasis, cell cycle progression, and apoptosis (Kristensen et al., 2019). Aberrant expression of circRNAs has been reported to be associated with lung cancer, acute respiratory distress syndrome, tuberculosis (Liu et al., 2020; Wan et al., 2016; Wang et al., 2019), as well as pulmonary inflammation caused by exposure to environmental chemicals such as neodymium-oxide (Hua et al., 2019; Xue et al., 2020), arsenic (Xiao et al., 2018) and cadmium (Chen et al., 2021; Wang et al., 2021). For copper, only one study in plants has found differentially expressed circRNAs following copper treatment (Fu et al., 2019). The effect of copper on the expression of circRNAs in CRDs or pulmonary inflammation has not been reported.

Herein, we evaluated expression of circRNAs in CRD. We identified nine CRD-related circRNAs and evaluated the association of these circRNAs with urinary copper exposure and the inflammatory cytokines, IL-6 and IL-8. The evaluation was completed with 101 CRD patients and 161 healthy control subjects in Shijiazhuang, China. We found decreased circ_0008882 levels to be associated with higher levels of plasma copper and inflammatory cytokines. The role of circ_0008882 in airway inflammation, induced by copper, was assessed in vitro.

Section snippets

Study population

In this case-control study, eligible cases and control subjects, greater than or equal to 18 years of age, from seven communities in Shijiazhuang, China were recruited from March to April 2018. Cases were recruited by local Community Healthcare Centers and were diagnosed by doctors at the first admission episode of COPD, chronic bronchitis, obstructive pulmonary emphysema, or bronchial asthma (ICD-10 code: J40 to J46). The exclusion criteria were: (1) an acute infectious disease 1 week prior to

Subject characteristics

Table S1 summarizes the characteristics of the 101 CRD cases and 161 control subjects. The control subjects were demographically similar to the cases (all p > 0.05), except for age (case group vs. control group: 68.1 vs. 58.6 years) and smoking amount (11.2 vs. 5.1 pack-years). Compared with the control group, CRD patients had higher plasma cytokine levels of IL-6 and IL-8, though the difference in IL-6 was not significant (p = 0.95, Table 1).

Associations between plasma IL-6, IL-8, and CRDs

Table 2 presents associations among cytokines and

Discussion

In this study, we identified a CRD-related circRNA, circ_0008882, which was reduced in vitro and in vivo after copper exposure. Overexpression of circ_0008882 inhibited the copper induced expression of proinflammatory cytokines IL-6 and IL-8 by 16HBE cells. These results suggest that circ_0008882 regulates copper-induced inflammation in CRD patients.

Evidence for an association between circRNAs and heavy metal exposure has been recently reported (Liu et al., 2021; Wang et al., 2021). To the best

Conclusions

In this study, we identified nine circRNAs associated with an increased risk for CRDs, among which circ_0008882 was associated with urinary copper, plasma IL-6 and IL-8 levels. Circ_0008882 was shown to be involved in the regulation of copper mediated inflammatory responses in 16HBE cells. These findings suggest an important mechanistic association among circ_0008882, copper, IL-6, IL-8, and CRDs, providing new insight into CRDs and exposure copper.

Author contributions

Experiment design: Jialu Zhu, Hanyu Zhou.

Writing the manuscript: Zehao Chen.

Investigation: Hanyu Zhou, Yangyang Jia, Honglian Ruan, Qinqin Diao, Meizhen Li.

Conducting the experiment: Zehao Chen, Jialu Zhu, Liting Zheng, Shuwei Yao, Yaozheng Guo.

Data analysis: Yun Zhou, Zehao Chen.

Writing - Review & Editing: Yun Zhou, Yiguo Jiang.

Funding acquisition and Project administration: Yiguo Jiang.

Approval from the Ethics Committee of Guangzhou Medical University

Yiguo Jiang is applying for the Major Research Program of the National Natural Science Foundation of China titled “The role and mechanism of non-coding RNA in airway inflammation induced by atmospheric fine particulate matter” (approval number: 201607003). After review by the Medical Ethics Committee of Guangzhou Medical University, its research content and methods meet the medical ethics standards and requirements.

The Ethics Committee of Guangzhou Medical University.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

We thank Rongying Wang from the Second Hospital of Hebei Medical University for subject recruitment and sample collection. We also thank Jingzhou Wang from Guangzhou University for assistance with urinary copper determination. This study was supported by the National Natural Science Foundation of China (81872652, 91643204, and 82130095 to J.Y.), Natural Science Foundation of Guangdong Province (2018B030311019 to J.Y.), and the Key Medical Disciplines and Specialties Program of Guangzhou (

References (45)

  • J. Wang et al.

    Circular RNAs: a rising star in respiratory diseases

    Respir. Res.

    (2019)
  • K.G. Wu et al.

    Associations between environmental heavy metal exposure and childhood asthma: a population-based study

    J. Microbiol. Immunol. Infect.

    (2019)
  • H. Xue et al.

    circ_0000638 inhibits neodymium oxide-induced bronchial epithelial cell inflammation through the miR-498-5p/NF-κB axis

    Ecotoxicol. Environ. Saf.

    (2020)
  • P. Aghasafari

    A review of inflammatory mechanism in airway diseases

    Inflamm. Res.

    (2019)
  • P.J. Barnes et al.

    Chronic obstructive pulmonary disease

    Nat. Rev. Dis. Prim.

    (2015)
  • E. Bradford et al.

    The value of blood cytokines and chemokines in assessing COPD

    Respir. Res.

    (2017)
  • M.R. De Moraes et al.

    Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD

    Int. J. Chronic Obstr. Pulm. Dis.

    (2014)
  • Q. Deng et al.

    Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbons

    Environ. Health Perspect.

    (2014)
  • X.Z. Fu et al.

    Whole-transcriptome RNA sequencing reveals the global molecular responses and ceRNA regulatory network of mRNAs, lncRNAs, miRNAs and circRNAs in response to copper toxicity in Ziyang Xiangcheng (Citrus junos Sieb. Ex Tanaka)

    BMC Plant Biol.

    (2019)
  • Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Lancet Respir. Med.

    (2020)
  • X. Ge et al.

    A systematic review and meta-analysis of therapeutic efficacy and safety of alirocumab and evolocumab on familial hypercholesterolemia

    BioMed Res. Int.

    (2021)
  • U. Gehring et al.

    Particulate matter composition and respiratory health: the PIAMA Birth Cohort study

    Epidemiology

    (2015)
  • Cited by (12)

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text